CELL INTELLIGENCE · 肿瘤细胞治疗研究

一种替代性全人源抗 BCMA CAR-T 对既往接受过抗 BCMA CAR-T 的复发/难治性多发性骨髓瘤显示缓解

An alternative fully human anti-BCMA CAR-T shows response for relapsed or refractory multiple myeloma with anti-BCMA CAR-T exposures previously.